Monotherapy Likely Enough to Help Manage Atypical PAH, Study Says

Monotherapy Likely Enough to Help Manage Atypical PAH, Study Says

295983

Monotherapy Likely Enough to Help Manage Atypical PAH, Study Says

Treatment with a single medication (monotherapy) may be sufficient to help manage people with “atypical” pulmonary arterial hypertension (PAH), according to an analysis from four clinical centers in Germany. One-year survival of adults diagnosed with “atypical” PAH — those older than 65 and with multiple risk factors for heart disease — did not differ for patients on monotherapy compared with patients taking dual or triple combination therapies. The study, “Monotherapy in patients with pulmonary arterial…

You must be logged in to read/download the full post.